600380.SS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 10:00):

Joincare Pharmaceutical Group Industry Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and healthcare products primarily in China...

Stats
Šios dienos apimtis	18.85M
Vidutinė apimtis	12.03M
Rinkos kapitalizacija	23.41B
EPS	CNY0 ( 2023-10-25 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	16.72
ATR14	CNY0.0110 (0.09%)

Tūris Koreliacija

Ilgas: 0.10 (neutral)

Trumpas: 0.16 (neutral)

Signal:(52.726) Neutral

Joincare Pharmaceutical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Joincare Pharmaceutical Koreliacija - Valiuta/Žaliavos

0.03
( neutral )

0.11
( neutral )

0.00
( neutral )

-0.34
( neutral )

-0.17
( neutral )

0.66
( moderate )

Joincare Pharmaceutical Finansinės ataskaitos

Annual	2023
Pajamos:	CNY16.44B
Bruto pelnas:	CNY9.59B (58.34 %)
EPS:	CNY0.770

FY	2023
Pajamos:	CNY16.44B
Bruto pelnas:	CNY9.59B (58.34 %)
EPS:	CNY0.770

FY	2022
Pajamos:	CNY17.14B
Bruto pelnas:	CNY10.89B (63.53 %)
EPS:	CNY1.530

FY	2021
Pajamos:	CNY15.90B
Bruto pelnas:	CNY10.19B (64.06 %)
EPS:	CNY0.686

Financial Reports:

No articles found.

Joincare Pharmaceutical

Joincare Pharmaceutical Group Industry Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and healthcare products primarily in China. The company offers chemical drug preparation products, including respiration, gastroenterology, anti-infection, gonadotropic, and psychiatric products; and traditional chinese drug preparation production, which includes anti-tumor and cold products. It also provides chemical APIs and intermediates; diagnostic reagents and equipment, including autoimmunity multiple detection platform and diagnostic kit for IgM; and healthcare products, which includes American ginseng tea and Jingxin menocare essence. In addition, the company engages in the wholesale and retail of skin care products, cosmetics, and other necessities. It offers its products in various forms, such as hormone tablets, oral liquids, and tablets. The company was founded in 1992 and is headquartered in Shenzhen, China.